手術ロボットの市場規模：コンポーネント別、用途別、地域別、範囲および予測

手術ロボットの市場規模と予測

手術ロボットの市場規模は、2024年に100億3,000万米ドルと評価され、2024年から2031年にかけて17.97%のCAGRで成長し、2031年には335億5,000万米ドルに達すると予測されています。手術ロボットは低侵襲手術の一種で、コンピュータ制御のロボットシステムを利用して、手術中に外科医を支援します。ロボット手術は、自動化された技術を用いて行われる処置です。ロボット支援手術は、既存の低侵襲手術の欠点を解決し、従来の開腹手術を行う医師の能力を向上させるために考案されました。ロボット支援低侵襲手術では、道具を物理的に扱う代わりに、医師は2つのアプローチのうち1つを用いて道具を制御します。これらの方法には、直接テレマニピュレーターを使用する方法と、コンピューター制御を使用する方法があります。テレマニピュレーターとは、外科医が手術中に必要な正確な動作を行うための遠隔マニピュレーターです。その後、ロボットアームがエンドエフェクターや機器を使ってこれらの動きを模倣し、手術手順を実行します。コンピュータ制御システムでは、外科医はコンピュータ命令を使用してロボットアームやエンドエフェクタを駆動するが、これらのシステムには入力用のテレマニピュレータが残っている場合もあります。

コンピュータ制御の利点のひとつは、医師が物理的に立ち会う必要がないことで、遠隔手術が可能になる可能性があります。記憶装置は、シームレスなロボット支援手術を保証するために不可欠です。

これらの記憶ソリューションは、較正調整のための特定情報の保存、記憶決定システムの違いの検出、データの寿命の監視など、患者のカルテによって様々な目的を果たします。

参考資料として

手術ロボットの世界市場力学

世界の手術ロボット市場を形成している主な市場力学

主な市場促進要因

低侵襲アプローチ：

ロボット支援手術（RAS）は、従来の開腹手術に代わる低侵襲手術を提供します。このアプローチにより、切開創の縮小、出血量の減少、回復時間の短縮、術後疼痛の軽減など、患者にとっていくつかのメリットがもたらされます。また、切開創が小さくなることで感染のリスクも低下し、傷跡も最小限に抑えられるため、全体的な患者体験と治療成績が向上します。

精度とコントロールの向上：

RASは手術器具の精度と制御を強化します。ロボットアームは人間の手よりも高い精度で動作を実行できるため、手の震えを最小限に抑え、手術の精度を高めることができます。このような制御性の向上は、些細なミスが重大な結果をもたらしかねない複雑で繊細な手術に特に有益です。外科医は精度を向上させながら複雑な手術を行うことができ、より良い臨床結果につながります。

視覚化の向上：

RASシステムには、手術部位を拡大表示する高精細3Dカメラが搭載されています。この高度な可視化により、外科医は解剖学的構造を非常に詳細に見ることができ、手術中に十分な情報に基づいた意思決定が容易になります。組織や臓器の視認性が向上することで、重要な構造の特定と保存が容易になり、合併症の可能性が低下します。

低侵襲手術への需要の高まり：

従来の開腹手術よりも低侵襲手術を好む患者が増加しているため、低侵襲手術の需要が高まっています。回復時間の短縮、痛みの軽減、日常生活への早期復帰など、低侵襲手技の利点がこの動向を後押ししています。その結果、このような低侵襲手技をより正確かつ効果的に行うことができる手術ロボットに対する需要が高まっています。

人口の高齢化：

世界の人口の高齢化により、複雑な外科手術に対する需要が高まっています。高齢の患者には合併症があることが多く、従来の開腹手術はリスクが高いです。RASは手術に伴う身体的外傷を軽減するため、こうした患者にとってより安全な選択肢となります。ロボット手術の精度と低侵襲性により、回復が早く合併症の少ない高齢患者には特に適しています。

技術の進歩：

ロボット技術の絶え間ない進歩により、手術ロボットの能力と使いやすさが向上しています。最新の手術ロボットは、より洗練され、使いやすく、多機能になってきています。こうした進歩により、心臓病学、泌尿器科、婦人科、整形外科など、さまざまな外科専門分野にわたってロボット手術の応用範囲が広がっています。ロボットの器用さの向上、触覚フィードバック、AIの統合などの革新は、ロボット手術で達成できることの限界をさらに押し広げています。

政府の取り組み：

いくつかの国では、政府のイニシアティブと支援的な償還政策により、ヘルスケア施設における手術ロボットの導入が促進されています。このような取り組みには、ロボット手術プログラムへの資金援助、医療専門家へのトレーニング、病院が高度な手術技術に投資するインセンティブなどが含まれることが多いです。支援的な政策により、ロボットシステムの臨床への導入が大幅に促進され、これらの高度な処置が患者にとってより身近なものとなります。

ヘルスケアの効率化：

手術ロボットは、手術室での滞在時間を短縮し、手術ワークフローを強化することで、ヘルスケアの効率を向上させる可能性を秘めています。RASが提供する精度と制御は、合併症の少ない、より迅速で効率的な手術につながります。手術時間の短縮と回復の早さにより、入院期間と関連費用が削減されるため、このような効率化は全体的なヘルスケアコストの削減につながります。さらに、外科部門のスループットが向上することで、ヘルスケア施設は患者数をより効果的に管理し、外科治療へのアクセスを改善することができます。

主な課題

高コスト：

手術ロボットシステムの高額なコストは、普及の大きな障壁となっています。これらの先進的な機械は1台数百万米ドルもするため、病院や手術センターにとっては初期投資が高額になります。予算に制約のある環境、特に小規模または地方のヘルスケア施設では、これらのシステムの購入と維持に必要な資金を割り当てることが困難な場合があります。さらに、初期購入費用だけでなく、メンテナンス、修理、更新にも費用がかかり、財源をさらに圧迫します。

限られた償還：

ロボット手術に対する償還方針は一貫していないことがあり、国やヘルスケアシステムによっても大きく異なります。多くの場合、保険や政府からの払い戻しは、ロボット手術に伴う追加費用を完全にカバーすることはできないです。このような経済的格差は、病院にとってロボット手術が魅力的な選択肢ではなくなる可能性があります。診療報酬が、発生する高い費用を正当化するものでない場合、病院はこれらの技術の採用をためらうかもしれないです。

険しい学習曲線：

手術ロボットを効果的に活用するには、外科医や手術スタッフに対する広範なトレーニングが必要です。このトレーニングには、ロボットシステムの操作方法の習得だけでなく、新しい手術手技やプロトコールへの適応も含まれるため、時間とコストがかかります。病院は、このような高度な手術を提供する前に、教育やトレーニングに多大なリソースを投資する必要があるため、学習曲線が険しいと、ロボット手術プログラムの導入が遅れる可能性があります。また、技術の進歩に対応するための継続的なトレーニングの必要性も、負担に拍車をかけています。

長期的データの欠如：

ロボット手術の短期的な利点は十分に証明されているが、患者の転帰を従来の手術法と比較した包括的な長期データはまだ不足しています。このようなデータのギャップは、ロボット支援手術の長期的な有効性や安全性が不明であるため、外科医や患者にためらいを生じさせる可能性があります。RASの利点と潜在的リスクについてより明確に理解するためには、長期的な研究が不可欠であり、これはRASの導入について十分な情報に基づいた意思決定を行うのに役立ちます。

限られた用途：

手術ロボットはすべての手術に適用できるわけではないです。この技術はまだ発展途上であり、従来の手技の方が効率的であったり、費用対効果が高かったりする手術には適さない場合もあります。手術によっては、ロボットによるアプローチは従来の方法と比較して大きな利点がなく、外科医が従来の手技を好む場合もあります。さらに、特定の手術手技のためのロボットシステムの開発は現在進行中であり、一部のアプリケーションはまだ臨床使用に完全に最適化されておらず、検証もされていないです。

主要動向

AIと機械学習の台頭：

人工知能（AI）と機械学習（ML）アルゴリズムの統合は、ロボット支援手術に革命をもたらしています。AIは外科医の手術中の意思決定を支援し、患者データを分析して潜在的な合併症を予測し、反復作業を自動化することができます。さらにMLは、個々の患者の解剖学的構造および病歴に合わせて手術手順をカスタマイズし、精度と治療成績を向上させることができます。

用途の拡大：

手術ロボットは現在、従来の泌尿器科や婦人科の領域を超えて活用されています。一般外科、心臓外科、頭頸部外科などにも新たな用途が生まれつつあります。ロボット技術の進歩に伴い、ロボット支援に適した手技の幅も広がっており、さまざまな医療分野での採用が期待されています。

費用対効果の重視：

手頃な価格であることは依然として重要な課題であるが、コスト抑制のためのソリューションが重視されるようになってきています。より低価格のロボットシステムの開発、革新的な資金調達モデルの導入、手術室の時間を最適化するための手術ワークフローの合理化が進められています。これらの対策は、ロボット支援手術をヘルスケア提供者にとってより身近で経済的に実行可能なものにすることを目的としています。

テレプレゼンスと遠隔手術：

技術の進歩により、遠隔手術への道が開かれつつあり、外科医が遠隔地からロボットを操作できるようになりつつあります。この機能は、十分な医療が行き届いていない地域や緊急時に、専門的な外科治療へのアクセスを向上させる可能性を秘めています。テレプレゼンス手術は、外科治療の提供方法に革命をもたらし、より多くの人々が専門的な処置を受けられるようになるかもしれないです。

触覚フィードバックの強化：

現在のロボットシステムでは触覚フィードバックが向上しており、外科医は手術中に組織の圧力や抵抗を感じることができます。強化された触覚フィードバックは、従来の開腹手術の感覚に近く、より自然で直感的な体験を提供します。この進歩により、外科医はより正確で自信に満ちた手術を行うことができます。

協働ロボットの出現：

新世代の協働手術ロボットが登場しつつあります。これらのロボットは、外科医の代わりというよりはむしろ助手として機能するように設計されており、手術器具の保持や組織の引き込みなどの作業を行う。この協調的アプローチは、手術効率を高め、外科医の疲労を軽減し、全体的な手術結果を改善することができます。

サイバーセキュリティへの注目の高まり：

手術ロボットが複雑なソフトウェアやデータシステムとますます統合されるにつれて、サイバーセキュリティへの懸念が最重要視されるようになっています。業界は、患者データを保護し、ロボットシステムの安全な運用を保証するために、強固なサイバーセキュリティ対策の開発に注力しています。強力なサイバーセキュリティ・プロトコルを導入することは、ロボット支援手術の信頼性と安全性を維持するために不可欠です。

目次

第1章 手術ロボットの世界市場：イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• 検証
• データソース一覧

第4章 手術ロボットの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会

第5章 手術ロボットの世界市場：コンポーネント別

• 概要
• コンポーネント
  • ロボットシステム
  • 器具と付属品

第6章 手術ロボットの世界市場：用途別

• 概要
  • 整形外科
  • 脳神経外科
  • 一般外科
  • 婦人科手術
  • 泌尿器外科
  • その他

第7章 手術ロボットの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ
  • その他中東とアフリカ

第8章 手術ロボットの世界市場：競合情勢

• 概要
• 企業市場ランキング
  • Intuitive Surgical, Inc. (US)
  • Stryker Corporation (US)
  • Mazor Robotics (Israel)
  • Hansen Medical (US)
  • TransEnterix, Inc. (US)
  • Medtech SA (France)
  • Merck Co. & Inc (US)
  • Verb Surgical Inc. (US)
  • Smith & Nephew (UK)
  • Renishaw PLC (UK)
  • Medrobotics Corporation (US)
• 主な開発戦略

第9章 付録

• 関連レポート

Surgical Robotics Market Size And Forecast

Surgical Robotics Market size was valued at USD 10.03 Billion in 2024 and is projected to reach USD 33.55 Billion by 2031, growing at a CAGR of 17.97% from 2024 to 2031. Surgical robotics is a type of minimally invasive surgery that utilizes computer-controlled robotic systems to assist surgeons during procedures. Robotic surgeries are procedures carried out employing automated technology. Robotically-assisted surgery was created to solve shortcomings in existing minimally invasive surgical procedures and to improve the ability of doctors doing traditional open surgeries. Instead of physically handling tools in robotically-assisted minimally invasive surgery, physicians use one of two approaches to control them. These methods include using a direct telemanipulator and computer control. A telemanipulator is a remote manipulator that allows surgeons to perform the precise movements required during surgery. Robotic arms then imitate these movements with end-effectors and equipment to carry out the surgical procedure. In computer-controlled systems, surgeons use computer orders to drive robotic arms and end-effectors, while these systems may still have telemanipulators for input.

One advantage of computerized control is that doctors are not required to be physically present, which could enable remote surgery. Memory devices are critical for guaranteeing seamless robot-assisted operations.

These storage solutions serve a variety of purposes depending on patients' medical records, including storing specific information for calibration adjustments, detecting differences in the storage determination system, and monitoring data longevity, among other things.

To Learn More:

Global Surgical Robotics Market Dynamics

The key market dynamics that are shaping the global surgical robotics market include:

Key Market Drivers

Minimally Invasive Approach:

Robotic-assisted surgery (RAS) offers a minimally invasive alternative to traditional open surgery. This approach results in several patient benefits, including smaller incisions, reduced blood loss, quicker recovery times, and less postoperative pain. The smaller incisions also lower the risk of infection and lead to minimal scarring, improving the overall patient experience and outcomes.

Enhanced Precision and Control:

RAS is the enhanced precision and control over surgical instruments. Robotic arms can execute movements with greater accuracy than human hands, minimizing hand tremors and enhancing surgical precision. This increased control is especially beneficial for complex and delicate procedures, where even minor errors can have significant consequences. Surgeons can perform intricate operations with improved accuracy, leading to better clinical outcomes.

Improved Visualization:

RAS systems are equipped with high-definition 3D cameras that provide magnified views of the surgical site. This advanced visualization allows surgeons to see anatomical structures in exceptional detail, facilitating more informed decision-making during surgery. The enhanced visibility of tissues and organs helps in identifying and preserving vital structures, reducing the likelihood of complications.

Growing Demand for Minimally Invasive Procedures:

The demand for minimally invasive procedures is rising as patients increasingly prefer these options over traditional open surgeries. The benefits of minimally invasive techniques, such as shorter recovery times, reduced pain, and quicker return to daily activities, are driving this trend. Consequently, there is a growing demand for surgical robots, which enable these less invasive procedures to be performed with greater precision and efficacy.

Aging Population:

The global population is aging, resulting in a higher demand for complex surgical procedures. Elderly patients often have comorbidities that make traditional open surgery riskier. RAS offers a safer alternative for these patients, as it reduces the physical trauma associated with surgery. The precision and minimally invasive nature of robotic surgery make it particularly suitable for elderly patients, who may experience faster recovery and fewer complications.

Technological Advancements:

Continuous advancements in robotics technology are enhancing the capabilities and usability of surgical robots. Modern surgical robots are becoming more sophisticated, user-friendly, and versatile. These advancements are expanding the range of applications for robotic surgery across various surgical specialties, including cardiology, urology, gynecology, and orthopedics. Innovations such as improved robotic dexterity, haptic feedback, and AI integration are further pushing the boundaries of what can be achieved with robotic surgery.

Government Initiatives:

In several countries, government initiatives and supportive reimbursement policies are promoting the adoption of surgical robots in healthcare facilities. These initiatives often include funding for robotic surgery programs, training for healthcare professionals, and incentives for hospitals to invest in advanced surgical technologies. Supportive policies can significantly accelerate the integration of robotic systems into clinical practice, making these advanced procedures more accessible to patients.

Increased Focus on Healthcare Efficiency:

Surgical robots have the potential to improve healthcare efficiency by reducing the time spent in the operating room and enhancing surgical workflows. The precision and control offered by RAS can lead to faster, more efficient surgeries with fewer complications. This efficiency can translate to lower overall healthcare costs, as shorter surgeries and quicker recoveries reduce hospital stays and associated expenses. Additionally, the increased throughput in surgical departments can help healthcare facilities manage patient loads more effectively, improving access to surgical care.

Key Challenges

High Cost:

The high cost of surgical robotic systems represents a significant barrier to widespread adoption. These advanced machines can cost millions of dollars each, making the initial investment steep for hospitals and surgical centers. Budget-constrained environments, particularly in smaller or rural healthcare facilities, may find it challenging to allocate the necessary funds for purchasing and maintaining these systems. Additionally, the cost extends beyond the initial purchase, encompassing maintenance, repairs, and updates, further straining financial resources.

Limited Reimbursement:

Reimbursement policies for robotic surgery procedures can be inconsistent, varying widely across countries and even within different healthcare systems. In many cases, insurance and government reimbursements may not fully cover the additional costs associated with robotic surgery. This financial gap can make robotic surgery a less attractive option for hospitals, as they might not recoup their investments adequately. Hospitals may hesitate to adopt these technologies if the reimbursement rates do not justify the higher expenses incurred.

Steep Learning Curve:

Effectively utilizing surgical robots requires extensive training for surgeons and surgical staff. This training is both time-consuming and costly, as it involves not only learning how to operate the robotic systems but also adapting to new surgical techniques and protocols. The steep learning curve can delay the implementation of robotic surgery programs, as hospitals need to invest significant resources in education and training before, they can offer these advanced procedures. The need for ongoing training to keep up with technological advancements adds to the burden.

Lack of Long-Term Data:

While the short-term benefits of robotic surgery are well-documented, there is still a lack of comprehensive long-term data comparing patient outcomes to those of traditional surgical methods. This gap in data can create hesitation among surgeons and patients, as they might be uncertain about the long-term efficacy and safety of robotic-assisted procedures. Long-term studies are crucial to provide a clearer understanding of the benefits and potential risks associated with RAS, which can help in making informed decisions about its adoption.

Limited Applications:

Surgical robots are not universally applicable to all types of surgery. The technology is still evolving and may not be suitable for certain procedures where traditional techniques are more efficient or cost-effective. For some operations, the robotic approach may not offer significant advantages over conventional methods, leading surgeons to prefer traditional techniques. Additionally, the development of robotic systems for specific surgical procedures is ongoing, and some applications are not yet fully optimized or validated for clinical use.

Key Trends

Rise of AI and Machine Learning:

The integration of artificial intelligence (AI) and machine learning (ML) algorithms is revolutionizing robotic-assisted surgery. AI can aid surgeons in decision-making during procedures, analyze patient data to predict potential complications and automate repetitive tasks. Additionally, ML can personalize surgical procedures by tailoring them to the individual patient's anatomy and medical history, enhancing precision and outcomes.

Expanding Applications:

Surgical robots are now being utilized beyond their traditional domains of urology and gynecology. New applications are emerging in general surgery, cardiac surgery, and head and neck surgery. As robotic technology continues to advance, the range of procedures suitable for robotic assistance is expanding, promising broader adoption across various medical specialties.

Focus on Cost-Effectiveness:

Affordability remains a significant challenge, but there is a growing emphasis on cost-containment solutions. Efforts are being made to develop more affordable robotic systems, introduce innovative financing models, and streamline surgical workflows to optimize operating room time. These measures aim to make robotic-assisted surgery more accessible and economically viable for healthcare providers.

Telepresence and Remote Surgery:

Technological advancements are paving the way for telepresence surgery, enabling surgeons to operate robots remotely from distant locations. This capability has the potential to improve access to specialized surgical care in underserved areas and during emergencies. Telepresence surgery could revolutionize how surgical care is delivered, making expert procedures available to a broader population.

Enhanced Haptic Feedback:

Current robotic systems are improving haptic feedback, allowing surgeons to feel the pressure and resistance of tissues during surgery. Enhanced haptic feedback provides a more natural and intuitive experience, closely mimicking the sensations of traditional open surgery. This advancement helps surgeons perform procedures with greater accuracy and confidence.

Emergence of Collaborative Robots:

A new generation of collaborative surgical robots is emerging. These robots are designed to act as assistants rather than replacements for surgeons, performing tasks such as holding surgical instruments or retracting tissues. This collaborative approach can enhance surgical efficiency, reduce surgeon fatigue, and improve overall procedural outcomes.

Growing Focus on Cybersecurity:

As surgical robots become increasingly integrated with complex software and data systems, cybersecurity concerns are becoming paramount. The industry is focusing on developing robust cybersecurity measures to protect patient data and ensure the safe operation of robotic systems. Implementing strong cybersecurity protocols is essential to maintaining trust and safety in robotic-assisted surgery.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Surgical Robotics Market Regional Analysis

Here is a more detailed regional analysis of the global surgical robotics market:

North America

North America is substantially dominating the global surgical robotics market owing to the increasing number of surgical procedures in North America is a major driver of market expansion.

As the population ages and chronic disorders requiring surgical intervention become more common, the demand for sophisticated surgical solutions grows. Robotic-assisted operations, which are noted for their precision and low invasive nature, are increasingly popular among both surgeons and patients.

North America is a hotbed of technological innovation, and surgical robotics is no exception. Continuous improvements in robotic technologies, including as improved robotic arms, advanced imaging systems, and sophisticated AI-driven capabilities, improve the efficacy and safety of surgical procedures.

These technical advancements make robotic-assisted procedures more accessible and effective, accelerating their acceptance across a variety of medical disciplines.

The North American region has a considerable influence on the worldwide surgical robot industry. The market is being driven by a high degree of knowledge about the benefits of robotic-assisted operations among healthcare professionals and patients alike.

Educational campaigns and professional training programs are improving surgeons' competency in using these advanced technologies, consequently expanding their acceptance and use.

Higher surgical robot adoption rates in North America are also driving market expansion. Robotic systems are progressively being integrated into operating rooms by hospitals and surgical centers because of their advantages in terms of precision, decreased recovery periods, and improved patient outcomes.

Healthcare providers' willingness to invest in these technologies, despite their high initial costs, demonstrates the perceived value and long-term advantages of robotically assisted surgery.

Asia Pacific

Asia Pacific is anticipated to be the fastest-growing region in the global surgical robotics market owing to the region's tremendous economic growth, which has a substantial impact on the healthcare sector.

This economic boom is driving up investments in healthcare infrastructure and the deployment of modern medical technologies such as surgical robots. The region's economic vigor provides a perfect setting for the implementation of cutting-edge surgical treatments.

Increasing geriatric population in the APAC area. Mirroring global trends, the demographic shift toward an older population is increasing the incidence of chronic diseases and, as a result, the demand for complex surgical treatments.

Surgical robots, noted for their minimally invasive nature, are becoming increasingly popular among patients and healthcare practitioners due to their ability to shorten recovery periods and enhance surgical results.

They also play an important role in the adoption of surgical robots in the Asia-Pacific area. Several governments are actively promoting the development and implementation of these technologies through generous reimbursement policies and financing programs. Such initiatives boost market expansion by making modern surgical procedures more accessible to healthcare facilities.

The APAC region bears a tremendous burden of chronic diseases, such as cancer and cardiovascular disease. These disorders necessitate complicated surgical treatments, and surgical robots provide minimally invasive alternatives that can improve patient outcomes while lowering total healthcare expenditures. The rising illness burden is pushing the demand for better surgical technology.

Additionally, there is a rising emphasis on minimally invasive surgery in the APAC area. Patients and healthcare providers are increasingly preferring these procedures to their associated benefits, such as speedier recovery and less pain.

Surgical robots are well-suited to address this demand, as they offer precise and efficient solutions for a wide range of surgical needs. This propensity for fewer intrusive treatments is helping surgical robots gain traction in the market.

Global Surgical Robotics Market: Segmentation Analysis

The Global Surgical Robotics Market is segmented based on Component, Application, And Geography.

Surgical Robotics Market, By Components

• Robot Systems
• Instruments and Accessories

Based on the Component, the Surgical Robotics Market is bifurcated into Robots System and Instruments and Accessories. The robotic systems segment is showing significant growth in the Global Surgical Robotics Market owing to the advanced features including 3D-HD imaging and a wide range of surgical equipment required for surgical procedures. These technologies not only help surgeons spot problems, but they also make it easier to perform difficult surgical procedures thanks to their improved visibility and magnification capabilities, fueling market growth. Furthermore, the operation of robotic systems significantly reduces the risk of errors and post-operative complications, assuring the continuous growth and implementation of robotic technology in surgical settings.

Surgical Robotics Market, By Application

• Orthopedic Surgery
• Neurosurgery
• General Surgery
• Gynaecology Surgery
• Urological Surgery

Based on the Application, the Surgical Robotics Market is bifurcated into Orthopedic Surgery, Neurosurgery, General Surgery, Gynaecology Surgery, and Urological Surgery. The gynecology market is expanding rapidly due to the increased use of robotically assisted surgery for a variety of gynecological procedures. These include benign hysterectomy, myomectomy, and gynecologic cancer operations, among others. The FDA's acceptance of the da Vinci surgical system for gynecologic surgery has greatly increased the number of robotic surgeries performed in this discipline. Furthermore, the increasing frequency of C-section procedures and the growing patient desire for minimally invasive robotic-assisted surgeries are likely to fuel industry growth.

Surgical Robotics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Surgical Robotics Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is substantially dominating the Global Surgical Robotics Market owing to the increasing number of surgical procedures in North America is a major driver of market expansion. As the population ages and chronic disorders requiring surgical intervention become more common, the demand for sophisticated surgical solutions grows. Robotic-assisted operations, which are noted for their precision and low invasive nature, are increasingly popular among both surgeons and patients. North America is a hotbed of technological innovation, and surgical robotics is no exception. Continuous improvements in robotic technologies, including as improved robotic arms, advanced imaging systems, and sophisticated AI-driven capabilities, improve the efficacy and safety of surgical procedures.

Key Players

• The "Global Surgical Robots Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Intuitive Surgical, Inc., Stryker Corporation, Mazor Robotics, Hansen Medical, TransEnterix, Inc., Medtech SA, Merck Co. & Inc., Verb Surgical, Inc., Smith & Nephew, Renishaw PLC, Medrobotics Corporation.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Surgical Robots Market Recent Developments
• In August 2021, Medtronic, a global leader in medical technology, is expected to reach some regulatory hurdles for its soft-tissue robot. CEO Geoff Martha revealed in a recent earnings call that the company is on its approach to submitting for a CE mark and is expecting a new device rejection from the FDA for the highly anticipated soft-tissue surgical robot.
• In February 2022, Kinova announced the signing of a five-year contract agreement with Auris Health. According to the agreement, the firm will work with Auris to develop its Monarch robotic-assisted surgery system.
• In November 2021, Merck & Co., Inc. announced that it is collaborating with Synthekine Inc. to use the latter's unique surrogate cytokine agonist participate in the discovery, development, and marketing of new cytokine therapies. Under the terms of the agreement, Synthekine will conduct initial research, while Merck will have exclusive rights to develop, manufacture, and commercialize surrogate cytokine agonists for up to two cytokines.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL SURGICAL ROBOTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 List of Data Sources

4 GLOBAL SURGICAL ROBOTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities

5 GLOBAL SURGICAL ROBOTS MARKET BY COMPONENTS

• 5.1 Overview
• 5.2 Components
  • 5.2.1 Robot systems
  • 5.2.2 Instruments and accessories

6 GLOBAL SURGICAL ROBOTS MARKET BY APPLICATION

• 6.1 OVERVIEW
  • 6.1.1 Orthopaedic surgery
  • 6.1.2 Neurosurgery
  • 6.1.3 General surgery
  • 6.1.4 Gynaecology surgery
  • 6.1.5 Urologic Surgery
  • 6.1.6 Others

7 GLOBAL SURGICAL ROBOTS MARKET BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 South Africa
  • 7.6.4 Rest of Middle East and Africa

8 GLOBAL SURGICAL ROBOTS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
  • 8.2.1 Intuitive Surgical, Inc. (US),
  • 8.2.2 Stryker Corporation (US),
  • 8.2.3 Mazor Robotics (Israel),
  • 8.2.4 Hansen Medical (US),
  • 8.2.5 TransEnterix, Inc. (US),
  • 8.2.6 Medtech SA (France),
  • 8.2.7 Merck Co. & Inc (US),
  • 8.2.8 Verb Surgical Inc. (US),
  • 8.2.9 Smith & Nephew (UK),
  • 8.2.10 Renishaw PLC (UK),
  • 8.2.11 Medrobotics Corporation (US)
• 8.3 Key Development Strategies

9 Appendix

• 9.1.1 Related Reports